Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics
Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health.
Virtual healthcare provider Teladoc Health Inc. (NYSETDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Him & Hers Health Inc. (NYSEHIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication
LifeMD Inc. (NASDAQLFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing
NEW YORK, NY / ACCESSWIRE / August 16, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 17-18, 2022. The links can also be found at www.sidoticonference.com/events.
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Spring into Action: VIRTUAL begins on Monday, May 16th, 2022, with a Biotech Discovery Day. Company presentations begin at 1:30 PM Eastern Time. Presentations will be
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time. Presentations will be webcast on Tuesday and
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Summer Solstice - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, June 1, 2021, with company presentations beginning at 9am Eastern Time. Presentations will be webcast on
In the first sentence, the name and case number of the lawsuit should read Cho v. LifeMD, Inc., No. 21-cv-04004 (instead of Owens v. LifeMD, Inc., No. 21-cv-03384).
Robbins Geller Rudman & Dowd LLP announces that purchasers of LifeMD, Inc. (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”) have until June 15, 2021 to seek appointment as lead plaintiff in the LifeMD class action lawsuit, Owens v. LifeMD, Inc., No. 21-cv-03384 (S.D.N.Y.), which is assigned to Judge Paul A. Crotty.
Shareholder rights law firm Robbins LLP reminds investors that a purchaser of LifeMD f/k/a Conversion Labs, Inc. (NASDAQLFMD) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between January 19, 2021 and April 13, 2021. LifeMD is direct-to-patient telehealth company that purports to help patients access licensed providers for diagnose, virtual care, and prescription medications.
San Diego, CA -- (SBWIRE) -- 04/27/2021 -- An investor, who purchased shares of (NASDAQLFMD), filed a lawsuit against LifeMD, Inc. over alleged violations of Federal Securities Laws.
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQLFMD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired LifeMD securities between January 19, 2021 and April 13, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/lfmd.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 15, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”).
Shareholder rights law firm Robbins LLP announces that a purchaser of LifeMD f/k/a Conversion Labs, Inc. (NASDAQLFMD) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between January 19, 2021 and April 13, 2021. LifeMD is direct-to-patient telehealth company that purports to help patients access licensed providers for diagnoses, virtual care, and prescription medications.
Law Offices of Howard G. Smith reminds investors of the upcoming June 15, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”).
Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of LifeMD (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”). The case is captioned Owens v. LifeMD, Inc., No. 21-cv-03384, and is assigned to Judge Paul A. Crotty. The LifeMD class action lawsuit charges LifeMD and certain of its executives with violations of the Securities Exchange Act of 1934.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased LifeMD, Inc. (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”). Investors have until June 15, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”). LifeMD investors have until June 15, 2021 to file a lead plaintiff motion.
The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Owens v. LifeMD, Inc., et al., (Case No. 1:21-cv-03384) on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQLFMD) securities between January 19, 2021 and April 13, 2021, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).
